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ABSTRACT 
 
Background: Tuberculosis is a communicable disease that remains a major public health issue 
worldwide. Tuberculosis epidemics have become a primary public health concern for the last few 
decades. The problem becomes aggrevated due to the emergence of Multiple Drugs Resistant 
Tuberculosis (MDR-TB). It is estimated there are 6,100 MDR-TB cases annually in Indonesia. 
Grobogan is one of the 6 districts in ex-residential Pati in Central Java with the second highest 
MDR-TB cases after Kudus. Between 2011 and 2016 the annual incidence was 23 cases with case 
fatality rate of  52.17%. This study aimed to investigate the different roles of MDR-TB patients, 
families, TB  progammers, and health providers, in the incidence of MDR-TB in Grobogan, Central 
Java. 
Subjects and Method: This was an analytic qualitative study with case study approach. The 
study was conducted at Grobogan, Central Java, from May to June 2017. A total of 26 informants 
were selected purposively for this study, consisting of 7 MDR-TB patients, 7 family members who 
served as drug-taking supervisor, 7 TB programmers at Community Health Centers, 1 TB 
programmer at District Hospital, 3 Community Health Center doctors, and 1 District Hospital 
doctor. The data were collected by in-depth interview, direct observation, and document review. 
Interactive analysis was used to analyze data, including data collection, reduction, presentation, 
and verification. 
Results: All MDR-TB patients had favorable perceived susceptibility, perceived severity, and self-
efficacy, that drove them to adhere to TB treatment. Most patients reported that the treatment was 
beneficial. The existing barrier was not of serious concern that made them to stop treatment. 
Families of the patients had positive attitude towards TB treatment so they provided the necessary 
support in acessing treatment and adherence to treatment. However, TB program management at 
District Hospital, was sub-optimal as it did not administer appropriately the standard DOTS-TB 
treatment guideline, despite the existence of TB standard operating procedure. Likewise, TB 
treatment management by hospital doctors and private practice doctors was inadequate, due to the 
lack of DOTS-TB training. The lack of adherence in implementing thestandard DOTS-TB treatment 
guideline was the dominant causal factor for the incidence of MDR-TB in Grobogan district, 
Central Java. 
Conclusion: Adequate DOTS-TB treatment management and quality health services at both 
primary and secondary level facilities are needed in the efforts to prevent MDR TB. It is suggested 
that the government through the District Health Office hold DOTS-TB promotion program and 
invest in developing skilled DOTS-TB providers. 
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BACKGROUND 
Tuberculosis (TB) is one of the infectious 
diseases which is still a public health pro-
blem in the world. In the past decade, the 
epidemic situation of TB in the world has 
become increasingly alarming. The number 
of cases continues to increase, especially in 
22 countries with high tuberculosis burden. 
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According to WHO (2013), Indonesia is the 
third largest country after India and China 
with a prevalence of 700,000 cases per year 
with a mortality rate of 27 per 100,000 
population (Suharyo, 2013).  
Based on the WHO report (2015), it is 
estimated that there are approximately 9 
million TB cases in the world with 1.5 
million of them dead in 2013. This situation 
is exacerbated by the emergence of 
increasing cases of drug-resistant TB (TB 
Multiple Drug Resistant-TB MDR), appro-
ximately 480,000 new cases with 170,000 
of them dead. Approximately 10% are 
found and treated, the recovery rate of 48% 
and approximately 9% were XDR TB cases 
(exstensive Drug Resistant Tuberculosis) 
which are difficult to treat (Zumla et al., 
2015). he productive age group (15-50 
years) dominated TB patients with a propo-
rtion of 75%. This situation has an impact 
on the loss of annual household income of 
around 20-30% and if they die, it has an 
impact on losing income of around 15 years 
(RI Ministry of Health, 2014).  
Based on The Global Plan to Stop TB 
in 2006-2015, approximately 1.6 million 
people with MDR TB in the world are 
planned to undergo treatment and 60% of 
them are in countries with high tuber-
culosis burden. Global WHO Report (2013), 
Indonesia ranks 8th out of 27 countries 
with the largest MDR TB cases. The inci-
dence of MDR TB in Indonesia is estimated 
at 6,100 cases per year or an estimated 
number of cases of MDR TB of 2% of the 
number of new TB cases and 12 of cases of 
TB re-treatment (Ministry of Health, 2014). 
According to the Central Java Pro-
vincial Health Office (2016) report, there 
were 1500 suspected MDR TB, 210 of which 
were MDR Confirmed TB and 163 cases 
underwent treatment in 2015. Further-
more, there was an increase with the disco-
very of 1948 suspected MDR TB, 220 cases 
were confirmed MDR TB and 140 among 
were treated in 2016. During 2011-2016 
there were 638 cases treated, but the new 
cure rate reached 211 cases (33.07%) and 
the mortality rate reached 161 cases 
(25.24%). Lost to Follow Up cases were 73 
cases (11.44%), still treated 192 cases 
(30.09%) and only 1 case (0.16%) resulting 
in treatment. 
Grobogan is one of the regencies with 
the second largest number MDR TB cases 
in ex. Pati Residency, Central Java Pro-
vince. There was 23 cases found in 2011-
2016. The cure rate only reached 4 cases 
(17.39%) and the mortality rate reached 12 
cases (52.17%), while 2 cases (8.70%) 
released treatment (Lost to Follow Up) and 
5 cases (21.74%) were still on treatment. 
MDR TB is a serious threat to the 
population in the world and has become a 
concern for people in various countries in 
the world, considering that treatment is 
difficult and requires considerable costs. 
The causes of resistance to anti-tuber-
culosis drugs include 1) treatment provided 
by inadequate medical providers (types), 
types, dosages, amounts and anti-tuber-
culosis drugs alloys not DOTS standards 
taking TB drugs regularly 3) low family 
support in motivating patients during treat-
ment (Sarwani et al, 2012). Treatment 
procedures by providers that do not meet 
DOTS standards include inappropriate 
diagnosis; administration of anti-tuber-
culosis drugs with doses, types, incorrect 
number of alloys and inadequate treatment 
period are the causes of MDR TB (Nugra-
heni and Malik, 2015). 
A study by Desmukh et al (2015) and 
Shean et al (2013) on the success of MDR 
TB treatment showed that the low cause of 
successful MDR TB treatment was the side 
effects of excessive medication felt by pati-
ents, the burden of taking many drugs (> 10 
pills) and drug injection up to 8 months 
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and a long treatment period of up to 24 
months. 
The magnitude of MDR TB cases in 
Grobogan Regency with the number of 
cases increasing every year, where the 
mortality rate reached more than half 
(52.17%) and the low cure rate as a result of 
drug side effects and the burden of taking 
excessive medication. This fact encourages 
the need for early prevention efforts to 
reduce the risk of MDR TB cases. The 
interesting thing to be concerned is the 
need to do an in-depth study of various 
aspects that cause drug resistance in the 
perspective of the treatment process that 
was passed earlier. This study covered the 
behavior of patients during previous 
treatment, family support behavior during 
treatment, the quality of TB program 
management in health care facilities and 
treatment management by the provider. 
 
SUBJECTS AND METHOD 
1. Study Design 
This was an analytic qualitative study with 
a case control design. The study informants 
were MDR-TB patients, family members 
who served as drug-taking supervisor, TB 
programmers and doctors at Community 
Health Centers and District Hospital. 
According to Denzin and Lincoln 
(2009), qualitative study is a type of study 
whose findings all of which are not obtain-
ed through statistical procedures, subject 
conditions are not influenced by the 
researchers' strict treatment.  Whereas, the 
interpretive point of view is that the inter-
pretation of data (conclusions) ideologically 
specifies the case rather than following the 
law of generalization.  
The qualitative study design with a 
single fixed case study strategy was carried 
out to obtain a basic description and con-
cept of behavior, find unexpected characte-
ristics and relationships about an event of 
drug resistance in TB patients. Case studies 
are empirical inquiry that investigates 
phenomena in real life contexts, research 
has only a small chance or has no opportu-
nity at all to control the events studied (Yin, 
2005). 
This study was carried out in the 
Grobogan Regency area which included 7 
Community Health Centers areas that were 
found to be MDR TB cases and provided 
MDR TB treatment services and 2 hospitals 
that were the places for previous TB 
treatment. 
This study was conducted from May 5, 
2017 to June 3, 2017. The interview time 
was adjusted according to the informants' 
availability starting from 9 a.m to 9 p.m. 
2. Study Sample 
The study subjects are selected based on the 
criteria determined by the researcher and 
were expected to provide rich information 
voluntarily (Moleong, 2007). The method 
of selecting informants focuses on one case 
of MDR TB that was found and treated, 
arguing that the case chosen was proof of 
the theory that had been well developed 
and the case was a special opportunity for 
researchers because of the ease of access 
possessed to conduct study (Yin, 2005). 
The selection of informants with a purpo-
sive sampling approach, in which research-
ers determined the criteria for study 
subjects was 1) MDR TB patients diagnosed 
and treated in health care facilities referral 
to MDR TB treatment and continuing 
treatment at MDR TB satellite health care 
facilities 2) MDR TB patients who had been 
declared cured, still on treatment or off 
treatment. Furthermore, the strategy of 
selecting supporting informants was done 
using the Snow Balling Sampling approach, 
which was based on the information 
provided by the main informants (people 
with MDR TB).  
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The study subjects are prioritized who 
provide information density, the sample 
size is said to be sufficient, researchers are 
satisfied and sufficient, which the infor-
mation obtained is rich in information and 
include the dimensions studied until data 
saturation is achieved (Murti, 2013) 
The data sources used in this study 
included MDR7 TB patients. Supporting 
informants were 7 family members who 
served as drug-taking supervisor, 7 TB 
programmers at Community Health Cen-
ters and 1 TB programmer at District Hos-
pital, 3 Community Health Center doctors 
and 1 District Hospital doctor. The total 
number of informants was 26 people in 
Grobogan Regency. 
3. Data Collecion Techniques 
Data was collected using in-depth inter-
views, observations, and documentation 
studies. The technique of checking the vali-
dity of the data used is the triangulation 
technique, namely triangulation of data 
(sources), methods and theories. Data 
triangulation was done with various data 
sources, namely main and supporting 
informants. Whereas, method triangulation 
was done by using data collection by obser-
vation, in-depth interviews and documen-
tation studies. The data analysis technique 
used in the study was the interactive model 
of Miles and Huberman, which consisted of 
the stages of data collection, data reduction, 
data presentation and verification or 
conclusion drawing. 
This study applied the theory of 
Health Belief Model (HBM) to analyze the 
behavior of MDR TB patients in making 
prevention and treatment efforts for 
perceived health problems.  
 
RESULTS 
Based on the results of the study, it was 
found that the factors behind the occur-
rence of MDR TB cases in Grobogan 
Regency were as follows: 
The characteristics of most MDR TB 
sufferers were in the productive age group 
(15-50 years) of 4 people, and 3 people aged 
>50 years with an education level that was 
mostly less than high school as many as 5 
people. The patients' socio-economic status 
varied in their level of income. Their 
income that was less than 1.5 million as 
many as 4 people, and that was more than 
1.5 million as many as 3 people. The occu-
pational background of the sufferer also 
varied; 1 housewife, 1 private employee, 3 
employees and 2 retired employees. 
All MDR TB patients had a history of 
previous recurrent treatment, in hospitals, 
independent practice doctors and commu-
nity health centers. Treatment given in 
hospitals and independent practice doctors 
did not meet the TB DOTS guideline stan-
dards which included type, dose, amount, 
drug mix and duration of treatment given. 
Most sufferers underwent initial treatment 
at the hospital or at an independent prac-
tice doctor. This showed that patients 
believed in providers who provided medical 
services; that were an independent practice 
doctor and hospital compared to commu-
nity health centers. On average, the dura-
tion of treatment carried out in hospitals 
and independent practice doctors was more 
than 6 months. 
Regarding the perception of disease 
susceptibility, 5 out of 7 people (71%) MDR 
TB patients had a perception of suscep-
tibility to positive TB disease. This meant 
that TB sufferers understood that their TB 
disease was dangerous and they were at risk 
of transmitting it to other people, especially 
family members. Two informants admitted 
that at the beginning of treatment, they 
thought that TB disease suffered was a 
common thing like coughing in ge 
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neral. However, after undergoing the 
second treatment, then they understood 
that the disease was very dangerous.  
All informants were able to make 
efforts to prevent the transmission of the 
diseases, according to the knowledge they 
had obtained from the officers and infor-
mation media, such as posters and tele-
vision. Most of the sufferers stressed pre-
vention efforts to wear masks, did not 
throw sputum in places, did separation of 
cutlery and sleeping separately. 
Regarding the perception of severity 
in TB disease, all informants had a positive 
perception of the severity of their illness. 
This showed that TB disease was a serious 
problem that should have treatment. 
Repeated treatment and symptoms experie-
nced such as coughing up blood, the body 
became weak and weight loss made the 
patient aware of the seriousness of the the 
disease. 
The patients’ perception of the bene-
fits of the treatment taken was positive. 
Some sufferers felt the benefits of treat-
ment after the symptoms of coughing were 
reduced and the body felt good. Most of the 
informants decided to continue to undergo 
treatment because they had the motivation 
to recover and also the support of the 
family. Meanwhile, 1 sufferer decided to 
change treatment, after the treatment that 
was taken did not make him recover. 
Patients had positive perception of 
the perceived barriers to obtaining treat-
ment. All informants decided not to stop 
the treatment efforts that were carried out, 
because they were motivated to recover and 
also considered the family members they 
loved. The obstacle is in the form of medical 
expenses incurred, especially for patients 
who are treated in hospitals or doctors who 
practice independently. Most informants at 
the time of TB treatment did not have 
health insurance coverage at first. However, 
some sufferers had been registered as 
participants of the current national health 
insurance, so they did not have to pay to 
redeem prescription drugs. Access to 
remote health care facilities, the side effects 
of first-line TB drugs and the service 
attitude of some officers who were less sy-
mpathetic, did not make patients stop the 
treatment. 
The confidence of sufferers on the 
treatment taken (self-efficacy) were posi-
tive. All informants believed that the treat-
ment taken would provide healing. 5 out of 
7 informants (71%) started TB treatment in 
hospitals and independent practice doctors. 
This showed that the patients’ trust was 
large enough for the provider of health care 
facilities. Beliefs of sufferers were driven by 
motivation to recover, good clerical service 
and thoughts of family who still needed 
their attention. 
Family motivation and support for 
patients seeking treatment and adherence 
to treatment was positive. 6 of the 7 family 
members who served as drug-taking super-
visor or informants (85.7) realized their 
role was important. The informants reason-
ed that sometimes patients felt bored tak-
ing medication for a long time, so motiva-
tion from the family was needed. The role 
played by the family in ensuring the adhe-
rence of patients was to remind, prepare 
and ensure the drug had been taken. The 
reason for some informants to ensure 
compliance with taking medication for pati-
ents was because they were worried that 
when they dropped out they would have an 
impact on repetitive treatment. Family 
understanding of TB disease is the basis for 
building positive values and attitudes in 
providing support. All informants under-
stood that TB was dangerous and conta-
gious. 6 out of 7 informants (85.7%) were 
able to explain efforts to prevent trans-
mission that should be done, by empha-
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sizing wearing a mask, not throwing 
phlegm in any place, separating eating 
utensils and sleeping separately. An infor-
mant initially did not care about her 
husband's medication adherence because of 
her busy work. However, she always accom-
panied him when he went for treatment. 
After her husband underwent drug-resist-
ant TB treatment, the informant realized 
the importance of supervision support in 
taking medication and tried to always 
prepare the medicine to be taken. 
Education provided by TB program 
administrators and doctors to patients and 
their families had been done well, especially 
in Community Health Center. All TB staff 
informants and doctors at the Community 
Health Center had educated patients and 
families before starting the treatment. 3 out 
of 7 (42.87%) informants from TB Program 
Managers Community Health Center gave 
informed consent to patients and families 
before starting the treatment. This was an 
effort to emphasize patients, to seek regular 
treatment and not to discontinue treat-
ment. Based on information from the TB 
Program Manager in Community Health 
Center, it was known that almost no TB 
patients had dropped out of treatment and 
officers would make a home visit if there 
were cases of defaulting to treatment. The 
perceived obstacle was in TB treatment 
services in hospitals. A TB staff informant 
admitted that not all TB patients treated at 
the hospital received education from TB 
officers. This was due to the non-optimal 
functioning of the DOTS TB unit, even 
though the hospital already had TB service 
standard operating procedures (SOP). 
TB program management was 
supported by trained DOTS health person-
nels. 5 out of 7 people (71%) informants 
who managed TB programs at Community 
Health Centers trained in the TB DOTS 
program, only 2 officers had never attended 
a TB DOTS training program. However, the 
officer learned from the previous program 
manager. All TB Community Health Center 
staffs had a nursing education background. 
This made it easier for officers to und-
erstand the management of the DOTS TB 
program and all Community Health Center 
had implemented TB program management 
based on national TB guideline standards. 
The obstacle faced was the management of 
the TB program in the hospital did not 
work in accordance with the operational 
standards of TB services that had been set. 
Despite having TB program managers 
trained in TB DOTS, the numbers were still 
limited. Based on information from infor-
mants, hospital TB officers admitted that 
the DOTS TB unit that had been formed 
had not functioned optimally. This was due 
to the lack of commitment of the doctors 
and TB DOTS team in implementing the 
operational standards of TB service pro-
cedures that had been set, and also because 
the internal network of the TB DOTS team 
was still weak. 
The management of TB treatment by 
providers in hospitals and independent pra-
ctice doctors had not met the standards of 
the DOTS TB guidelines, in contrast to the 
providers in the Community Health Center 
that had implemented DOTS TB treatment 
procedures as a whole. 1 out of 3 Commu-
nity Health Center doctor informants had 
attended the TB DOTS training organized 
by the government. While 2 other people 
received DOTS TB treatment materials 
while studying at the medical school. One 
informant from a pulmonary specialist at 
the hospital had received TB DOTS train-
ing. Based on the information and acknow-
ledgment from a doctor and a TB program 
management officer who worked in the 
hospital, the diagnosis of TB by the 
majority of doctors in the service unit other 
than lung, was only based on radiological 
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examination of chest x-rays. Sputum 
examination to determine the presence of 
mycobacterium tuberculosis microsco-
pically was rarely done. This was at risk for 
overdiagnosis of TB because microscopic 
phlegm examination in the standard DOTS 
TB guidelines was a top priority in the 
diagnosis. 
TB treatment that carried out by some 
doctors in hospitals and independent 
practices had not met the standard DOTS 
TB guidelines. Based on information from a 
doctor and a TB manager at the hospital, 
they admitted that most doctors gave a 
single prescription drug at a cost of 300 - 
500 thousand for the patient to pay for the 
medicine. This is reinforced by the informa-
tion given by the majority of patients who 
were treated at the hospital or at inde-
pendent practice doctors that they spent 
the fee to redeem the medicine. TB drugs 
given with dosage, amount, type, drug mix, 
how to take medication, length and stages 
of treatment, did not meet the standard 
DOTS TB guidelines. 
The search results of medical docu-
ments on 2 MDR TB patients who were 
treated at the hospital, found that the com-
bination of TB drugs given to first-line TB 
treatment was incomplete; types of TB 
drugs, 2 - 3 kinds, coupled with second-line 
TB drugs (quinolones), drugs were recom-
mended to be taken 3 times a day, the treat-
ment stage was unclear and the treatment 
duration was more than 6-8 months. This 
showed inadequate TB treatment by some 
doctors who practiced in hospitals. 
Based on the TB DOTS guideline 
standard, first-line TB treatment was 
carried out for 6 months with a 2-month 
intensive phase with a mixture of 4 types of 
TB drugs namely Rifampicin (R), Isoniazid 
(H), Pirazinamide (Z), and Ethambuthol 
(E). While the next 4-month continuation 
phase continued with a mixture of 2 types 
of TB drugs namely Rifampicin (R) and 
Isoniazid (H). In the intensive phase, the 
drug was taken daily with a dose once a day 
and the continuation phase of the drug was 
taken 3 times a week with a dose once a day 
(Ministry of Health, 2014). 
The government has provided anti TB 
drugs for free in the form of FDC (Fixed 
Drugs Combination) packages. The drug 
was packaged in 1 tablet of intensive phase 
medicine containing 4 types of anti-
tuberculosis drugs (RHZE) and 1 tablet in 
the advanced phase containing 2 types of 
anti-tuberculosis drugs (RH). Giving the 
drug was easier and had minimal side 
effects. For patients who had side effects 
such as allergies to one type of anti-tuber-
culosis drugs, Kombipak anti-tuberculosis 
drug was provided which included RHZE 
medicine that are not packaged.  
The availability of FDC and Combipa-
ck anti-tuberculosis drug packages in the 
Community Health Center was sufficient. 
The Community Health Center only pro-
vided package of medicines from the 
government which were provided free of 
charge, as well as for phlegm examinations. 
The government had fulfilled anti-tuber-
culosis drugs and non anti-tuberculosis 
drugs logistical needs to ensure the quality 
of the DOTS TB program implementation. 
Non-anti-tuberculosis drugs  logistics pro-
vided by the government to support the 
diagnosis of TB include phlegm pots, smear 
glass, reagents. Based on information from 
TB staff and doctors at the Community 
Health Center, it was known that during 
this time there had never been a logistical 
vacuum between anti-tuberculosis drugs 
and non anti-tuberculosis drugs. To meet 
these needs, officers coordinated with the 
District Health Office to make requests. 
The government also provided anti-
tuberculosis drugs and non anti-tuber-
culosis drugs logistics for hospitals. How-
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ever, TB drugs available in hospitals vary, 
namely the FDC anti-tuberculosis drugs 
package from the government and anti-
tuberculosis drugs drugs provided by the 
hospital. Based on information from a 
resource person, a doctor and TB officer at 
the hospital, even though the FDC anti-
tuberculosis drugs package was available 
from the government, most doctors chose 
to use medicines that are not packaged. 
Meeting the needs of the FDC anti-
tuberculosis drugs package, carried out by 
the pharmacy department without coor-
dinating with TB officers to carry out calcu-
lation of needs. This showed that the imple-
mentation of TB DOTS program manage-
ment in hospitals was not optimal. 
 
DISCUSSION 
MDR TB is a condition that occurs in TB 
patients, which TB bacteria (Mycobacte-
rium Tuberculosis) are no longer able to be 
killed with anti-tuberculosis drugs. Immu-
nity to anti-tuberculosis drugs occur as a 
result of treatment of patients who are in-
adequate or infected by patients who are 
drug resistant (Ministry of Health, 2014). 
MDR TB is resistance to 2 types of first-line 
anti-tuberculosis drugs, Rifampicin (R) and 
Isoniazid (H) with or without other anti-
tuberculosis drugs resistance (Sembiring, 
2008). Factors that play a role in causing 
the incidence of MDR TB are inadequate 
treatment provided by the doctor (pro-
vider), behavior of patients who do not 
adhere to treatment, poor management of 
TB management (Ministry of Health, 2014) 
and poor family support (Sarwani, 2012). 
Based on the results of this study, 
most people with MDR TB had a history of 
repeated treatment. Patients first seek 
treatment in hospitals and doctors practice 
independently. Only a small proportion 
used the initial treatment at the Commu-
nity Health Center. Basically, patients and 
families chose treatment in hospitals and 
practice independently doctor because they 
had or were specialist experts. While at the 
Community Health Center, they did not 
provide. This showed the great trust of 
patients and families towards specialist 
health services in hospitals and indepe-
ndent practice doctor. But in reality, the 
management and treatment provided was 
not in line with the guidelines for DOTS TB 
treatment. The limitations of doctors 
trained in DOTS TB were factors that cause 
inadequate treatment of these services. 
History of re-treatment in TB patients 
occured due to incomplete treatment, so 
patients tend to move treatment because 
there was no change in the perceived health 
conditions. The results of the study were in 
line with the study conducted by Nugraheni 
and Malik (2015) which stated that a his-
tory of previous treatment could increase 
the risk by 10-fold compared to without a 
previous treatment history. 
This study showed that the patient 
had a positive perception of the vulnera-
bility of the illness. Patients assumed that 
TB was an infectious disease and was 
dangerous for themselves and risks trans-
mitting to other people, especially members 
of the closest family. It was this vulnera-
bility perception that encouraged patients 
to make efforts to prevent transmission of 
diseases such as wearing a mask, not thro-
wing phlegm in any place, closing the 
mouth and looking away when coughing, 
using separate cutlery and sleeping sepa-
rately with the closest family. This study wa 
in line with the theory of the Health Belief 
Model (HBM) proposed by Becker (1997) 
which explained that why people did 
certain healthy behaviors depend on two 
things: their perceived health threat and 
believe certain healthy behaviors could 
reduce the perceived health threats.  
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Another study conducted by Nurha-
yati et al. (2015) showed that the same res-
ults, namely perceptions of vulnerability 
encouraged someone to take preventive 
measures and treat their disease. A study by 
Safri et al. (2014) said that the vulnerability 
perception was influenced by good know-
ledge of TB patients obtained from educa-
tion of health workers. The better a 
person's knowledge, the more likely it will 
be to prevent and adhere to treatment. 
Another study conducted by Nur-
hayati et al. (2015) showed that the same 
results, namely perceptions of vulnerability 
encouraged someone to take preventive 
measures and treat their disease. A study by 
Safri et al. (2014) said that the vulnerability 
perception was influenced by good know-
ledge of TB patients obtained from educa-
tion of health workers. A better knowledge, 
the more likely it would be to prevent and 
adhere to treatment. 
Positive perceptions were also felt by 
patients of the seriousness/severity of their 
TB disease. Patients were aware of the 
seriousness of their disease that the disease 
could cause the danger of transmission, 
difficult treatment and relapse treatment 
that was undertaken. Symptoms such as 
coughing up blood, weak body and weight 
loss encouraged patients to realize the 
seriousness of the disease. One patient 
stopped treatment and then moved to 
another health care facility after treating 6 
months but their illness did not heal. This 
study showed that the seriousness/severity 
of the disease that was felt, encouraged a 
person to remain obedient to seek treat-
ment or try to find a place of treatment 
until recovery is obtained. 
The results of the study were in line 
with the Health Belief Model (HBM) theory 
proposed by Becker (1997) that perceptions 
of severity were based on a person's 
mindset about the extent to which the ill-
ness was truly a threat to him and seriously 
affects his organs. The same study results 
by Nugroho (2011) showed that perceived 
physical symptoms such as coughing up 
blood, weight loss, physical weakness and 
inability to engage in activities influenced 
the perception of patient severity and moti-
vation to follow doctor's instructions for 
recovery. 
Patients who did not experience 
changes in their health conditions, decided 
to continue to undergo treatment and 
adhere to treatment according to the 
doctor's instructions. However, 1 case was 
found that he did not experience changes in 
his health condition and then he decided to 
change treatment. 
Patients benefited from the treatment 
measures taken. Most sufferers experience 
reduced complaints such as a reduced fre-
quency of coughing and the body feels 
good. In line with Nurhayati et al (2015) 
study, the perception of positive benefits 
from the actions taken would increase self-
confidence to make prevention efforts and 
continue to undergo treatment. 
Obstacles experienced by patients in 
undergoing treatment did not make pati-
ents stop the treatment. Obstacles faced by 
patients included medical expenses 
incurred to redeem prescription drugs, 
especially for patients who seek treatment 
in hospitals and doctors who practice 
independently, access to far-reaching ser-
vices, perceived side effects of drugs, satu-
ration with duration of treatment. These 
constraints did not make patients and 
families decided to stop treatment. This 
showed that high motivation from patients 
to recover and good family support encou-
raged a person to continue to undergo 
treatment and obey the treatment. 
The same results obtained from a 
study by Nugroho (2011), a personal assess-
ment of barriers to health medication taken 
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could determine a personal decision to 
make prevention and treatment efforts. 
This depended on the perceived benefits 
and constraints that were felt. If the patient 
felt the benefits were far greater than the 
barriers, the patient would complete treat-
ment thoroughly. 
All TB patients had positive beliefs 
(self-efficacy) on the treatment taken. Their 
self-efficacy increased after feeling the 
benefits of treatment. The good attitude 
and service of a doctor/health worker had 
an impact on the trust of patients to under-
go treatment and adhere to treatment. High 
motivation to get healing, encouraged pati-
ents to be sure of the treatment they were 
undergoing. 
This study showed that families had a 
positive attitude to provide support for 
patients in seeking treatment, adherence to 
treatment. The positive attitude of the 
family in providing motivation for treat-
ment was influenced by the family's under-
standing of TB disease and the treatment 
process undertaken by family members. 
The results of the study revealed that most 
of the informants understood about TB and 
preventive efforts to be taken. Education 
provided by health workers to patients and 
families influenced the attitude of the 
family in taking action to make efforts to 
prevent and treat TB diseases suffered by 
family members. 
The results of this study indicated that 
the role of the family as a drug-taking 
supervisor was important and most of them 
had understood their role as drug-taking 
supervisors, and were able to carry out their 
duties. Most families realized that the long 
term TB treatment would have an impact 
on the saturation of patients to take medi-
cation so that assistance and supervision 
were needed. The form of support in medi-
cation adherence was to remind, prepare 
and assist patients when taking medication. 
The family provided support to ensure the 
continuity of treatment through the help of 
medical expenses and to bring sufferers to 
medical treatment. This showed a signifi-
cant role of the family in influencing the 
patient to make a decision to seek treat-
ment and adherence to treatment. 
The results of a study conducted by 
Desmukh (2015) suggested the same thing. 
Family support needed in an oral form in 
reminding the patients to take medicine, 
providing food and encouraging them to 
stay focused on their health, even though 
the treatment was long and difficult. 
Informative support in the form of advice, 
information and advice was also needed for 
patients in making decisions about the right 
actions regarding the prevention and 
treatment of their diseases (Nugroho, 
2011).  
Based on the theory presented by 
Green and Kreuter (2000), the family envi-
ronment is a reinforcing factor that pre-
dominantly influences directed individual 
behavior and tends to be open. A comfort-
able family environment has a strong 
response to the efforts made by family 
members to overcome the health problems 
faced. Such a situation allows families to be 
more concerned in taking action for their 
family members. The results of this study 
proved that the theory was in line with the 
study that had been done. 
Management of TB programs played a 
major role in ensuring adequate treatment 
for TB patients. Good program manage-
ment would reduce the risk of MDR TB 
cases. This was indicated by the majority of 
Community Health Centers in Grobogan 
Regency that had implemented the TB 
DOTS guideline standard in the manage-
ment of TB diagnosis and treatment, 
supported by trained personnel. Most TB 
health center managers had been trained in 
DOTS TB. Based on the information from 
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the TB management of the Community 
Health Centers, so far there had never been 
cases of dropping out of treatment, because 
if a patient was lost to follow-up, a home 
visit would be made. 
The implementation and manage-
ment of DOTS TB programs in hospitals 
was more difficult than the management in 
Community Health Centers. This was 
because the management of TB programs in 
hospitals involved many parties, especially 
doctors who were the key in TB treatment 
services. Although the hospital already had 
TB DOTS units intended for the treatment 
of TB patients, there had also been a DOTS 
TB Team and already had TB service 
standard operating procedures (SOP), but 
the reality was not working as expected. 
TB program managers are technical 
officers who were administratively respon-
sible, recording and reporting treated TB 
patients, managing TB treatment programs, 
providing education to patients and fami-
lies, scheduling phlegm re-control exam-
inations and coordinating with other health 
care facilities for referral or transfer of 
treatment. In line with the study conducted 
by Suharyo (2013), TB management officer 
played a role in providing education to 
patients and families, arranging medication 
administration and making home visits or 
calling if they were found to be absent from 
TB treatment. 
TB program managers had an import-
ant role in the compliance and success of 
patient treatment. A TB manager would 
plan a treatment program after the TB pati-
ent had been diagnosed and decided on 
treatment by a doctor. This process was not 
felt for TB managers in hospitals because 
after the patient had been treated by a 
doctor, then he immediately went to 
redeem prescription drugs at the pharmacy 
without meeting with TB officers. This was 
the impact of the non-optimal functioning 
of the DOTS TB unit in hospitals, and the 
lack of commitment in carrying out opera-
tional standards for TB service procedures. 
TB management in hospitals was an addi-
tional task not the main task. Trained TB 
managers should work with pulmonary 
specialists in lung units or TB DOTS. 
The District Health Office controlled 
and guaranteed the quality of the impleme-
ntation of TB DOTS treatment at the 
Community Health Center. Hierarchically, 
Community Health Center were under the 
guidance and supervision of the District 
Health Office. The management of TB 
treatment by doctors in the Grobogan 
district health center had implemented the 
DOTS TB guideline standard. This was 
supported by the trained DOTS doctors 
who had the obligation to implement TB 
DOTS service standards. This was different 
from hospitals that were parallel or in a 
hierarchical coordination relationship. 
Although the District Health Office had the 
responsibility of conducting guidance, in 
reality it was more difficult and had many 
obstacles. The implementation of TB treat-
ment procedures in independent practice 
services also had many obstacles. This was 
due to the limitations of trained TB DOTS 
personnel, especially in hospitals and inde-
pendent practice services. Although some 
puskesmas have networked TB programs 
with independent doctors and clinics in 
finding suspicion, sputum examinations 
and treatment, the reality was not optimal. 
Based on national TB program data, it 
was found that health service facilities were 
not fully involved in the TB control pro-
gram. In 2012, it is recorded that the Lung 
Health Center and Lung Hospital are 100%, 
Community Health Center reaches 98%, 
while government and private hospitals 
only 38% apply the DOTS TB treatment 
strategy. The trained staff of TB DOTS for 
Community Health Center has reached 
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98% and hospitals are only 24% (RI Minis-
try of Health, 2014). Utilization of health 
care facilities by the community for Java 
and Bali regions, shows that hospitals and 
pulmonary health centers are the most 
desirable facilities in seeking TB treatment 
with a utilization percentage of 44%, then 
35% of independent / clinical doctors and 
only 21% of Community Health Center. 
This is certainly a big obstacle in guarantee-
ing the quality of TB services in primary 
and secondary health care facilities, espe-
cially for hospitals and independent/clini-
cal practice doctors (Ministry of Health, 
2010). 
Diagnosis by some doctors who did 
not meet the TB DOTS guideline standards, 
which were only based on radiological exa-
mination of chest rongent photos without 
microscopic phlegm examination, would 
have an impact on the accuracy of TB diag-
nosis, namely over diagnosis. This resulted 
in the possibility that someone who was not 
infected with TB, but received TB treat-
ment. Based on the National TB Treatment 
guidelines stated that radiological exami-
nation of chest x-rays did not show a speci-
fic picture for TB. The truth could only be 
accounted for by 40%. While phlegm exam-
ination with specimens at a time-time (SPS) 
provided a picture of TB that the truth 
reached 98%. Some doctors in hospitals 
and independent practice rarely carried out 
sputum examinations because many 
doctors had not been trained in DOTS TB. 
Doctors had their own principles in esta-
blishing a diagnosis and required a longer 
time of 2-3 days to obtain results. 
Based on information from infor-
mants, a doctor and a TB manager in a hos-
pital, TB treatment provided by some 
doctors in hospitals and independent prac-
tices used more drugs with dosages, types, 
and mixtures of drugs that were not in 
accordance with TB guideline standards. 
Based on the search for medical documents 
of patients with MDR TB, a history of treat-
ment with second-line TB drugs (quinolon-
es) was obtained in first-line TB treatment. 
Duration of treatment more than 6 months, 
intensive and advanced treatment stages 
were unclear and how to take medication 
was given 3 times a day. This showed that 
TB treatment was inadequate, even though 
the hospital had a DOTS unit and standard 
operating procedures for TB services. But 
the fact was, it did not go as expected and 
package drugs were available, but rarely 
used. Economically, the administration of 
FDC drug packages from the government 
was free, whereas if the patients used 
medicines that were not packaged, he 
should pay 300 - 500 thousand. 
A study conducted by Fauziah (2013) 
states that TB treatment by health workers 
that do not use the right anti-tuberculosis 
drugs in administering doses, types, num-
ber of drugs and the duration of treatment 
is inadequate. Failure to identify resistant 
TB has an impact on the treatment of inad-
equate TB patients. 
Based on the description above, it can 
be concluded that 1) MDR TB patients have 
perceptions of vulnerability and seriousness 
of TB disease suffered, and also positive 
self-efficacy which encourages patient 
adherence to treatment. 2) Most patients 
feel the benefits of the treatment taken. The 
perceived obstacle does not make the 
sufferer to stop treatment because of the 
motivation to recover and the consideration 
of the loved ones 3) Families have a positive 
attitude in providing support for sufferers 
in seeking treatment and adherence to 
treatment 4) Education and service atti-
tudes provided by TB program managers 
and doctors play a role in increasing the 
confidence of patients undergoing treat-
ment, encouraging treatment compliance 
and also increasing family roles 5) Manage-
Journal of Epidemiology and Public Health (2017), 2(3): 186-200 
https://doi.org/10.26911/jepublichealth.2017.02.03.01 
198   e-ISSN: 2549-0273 
ment of TB programs in hospitals has not 
been optimal in implementing the TB 
DOTS guideline standards even though 
they already have operational standards for 
TB service procedures 6) Inadequate TB 
treatment management by some providers 
in hospitals and doctors who practice 
independently as a result of the limitations 
of trained TB DOTS personnel. Not impl-
ementing the DOTS TB treatment guideline 
standard is the dominant factor that causes 
the incidence of MDR TB in Grobogan 
Regency. 
Based on the conclusions above, it can 
be suggested that adequate TB treatment 
management in primary and secondary 
health care facilities that ensure service 
quality with the standard DOTS TB, is nee-
ded as an effort to prevent the incidence of 
MDR TB. The participation of the gove-
rnment through the District Health Office 
in promoting the TB DOTS program and 
preparing trained TB DOTS personnel for 
providers is very urgent. 
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